Abstract:Purpose: To evaluate early versus late immunomodulatory therapy (IMT) for patients following initial diagnosis of Vogt-Koyanagi-Harada (VKH) disease.
Methods:Retrospective review including all VKH patients seen 5/1/2014 to 4/1/2016 at LAC+USC. Early IMT was defined as starting an immunomodulatory agent within 3 months of corticosteroid initiation.Results: Twenty-seven patients were included, of whom 15 received early IMT and 8 received late IMT.Early IMT patients trended toward greater improvement in vision co… Show more
“…Case series have demonstrated that multiple regimens may be effective in controlling disease progression and reducing recurrence in patients who are poorly responsive or intolerant of steroids [58][59][60]. However, data are mixed as to whether starting these therapies initially may confer a superior visual outcome or reduced complications as compared to those initially treated with steroids alone and then switched to IMT [61]. Newer biologic agents such as infliximab, adalimumab, rituximab, and interferon alpha for the treatment of VKH have been described in case reports only [62][63][64].…”
Vogt-Koyanagi-Harada (VKH) disease is a systemic disease with characteristic ocular and extraocular findings. It can manifest in four stages: prodromal, acute uveitic, chronic, and chronic recurrent stages. Symptoms in the
“…Case series have demonstrated that multiple regimens may be effective in controlling disease progression and reducing recurrence in patients who are poorly responsive or intolerant of steroids [58][59][60]. However, data are mixed as to whether starting these therapies initially may confer a superior visual outcome or reduced complications as compared to those initially treated with steroids alone and then switched to IMT [61]. Newer biologic agents such as infliximab, adalimumab, rituximab, and interferon alpha for the treatment of VKH have been described in case reports only [62][63][64].…”
Vogt-Koyanagi-Harada (VKH) disease is a systemic disease with characteristic ocular and extraocular findings. It can manifest in four stages: prodromal, acute uveitic, chronic, and chronic recurrent stages. Symptoms in the
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.